When will Lamotrigine Tablet, Extended Release be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Lamotrigine Tablet, Extended Release changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Lamotrigine Tablet, Extended Release

Brand names: Lamotrigine Extended Release

Category: Neurology

Not specified 6

FDA status: To Be Discontinued · Last FDA update: Apr 29, 2026 · First posted: Apr 29, 2026 · 1 manufacturers, 6 listed presentations

As of Apr 29, 2026, the FDA lists Lamotrigine Tablet, Extended Release as being discontinued. Of 6 manufacturer presentations, 6 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Lamotrigine Tablet, Extended Release is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11) NDC 49884-561-11	Par Health, Inc.	Not specified	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11) NDC 49884-562-11	Par Health, Inc.	Not specified	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11) NDC 49884-563-11	Par Health, Inc.	Not specified	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11) NDC 49884-564-11	Par Health, Inc.	Not specified	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11) NDC 49884-604-11	Par Health, Inc.	Not specified	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11) NDC 49884-605-11	Par Health, Inc.	Not specified	Discontinuation of the manufacture of the drug

Related medications in shortage

Other Neurology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Lamotrigine Tablet, Extended Release (FDA data as of Apr 29, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Lamotrigine Tablet, Extended Release. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Lamotrigine Tablet, Extended Release.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/lamotrigine-tablet-extended-release.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).